CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Conversion Chief Scientific Officer acquired 750 shares (conversion)
- 4 Conversion Chief Financial Officer acquired 938 shares (conversion)
- 4 Conversion Director acquired 325 shares (conversion)
- PRE 14A Proxy Proxy Statement (Preliminary)
- EFFECT Other Notice of Effectiveness
- 4 Other acquisition Director acquired 8 shares (other)
- 4 Other acquisition Chief Scientific Officer acquired 17 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 22 shares (other)
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Other acquisition Chief Scientific Officer acquired 17 shares (other)
- 4 Other acquisition Director acquired 8 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 22 shares (other)
Page 17 of 47 · 929 filings